TECLISTAMAB for Primary amyloidosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where TECLISTAMAB was used for Primary amyloidosis.
Most Reported Side Effects for TECLISTAMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 257 | 21.1% | 37 | 98 |
| Pneumonia | 101 | 8.3% | 39 | 83 |
| Plasma cell myeloma | 100 | 8.2% | 51 | 22 |
| Immune effector cell-associated neurotoxicity syndrome | 99 | 8.1% | 34 | 45 |
| Pyrexia | 86 | 7.0% | 25 | 52 |
| Covid-19 | 82 | 6.7% | 21 | 32 |
| Infection | 58 | 4.8% | 17 | 20 |
| Drug ineffective | 52 | 4.3% | 11 | 12 |
| Neutropenia | 48 | 3.9% | 7 | 15 |
| Sepsis | 48 | 3.9% | 36 | 41 |
| Febrile neutropenia | 44 | 3.6% | 5 | 38 |
| Death | 34 | 2.8% | 34 | 5 |
| Off label use | 34 | 2.8% | 11 | 11 |
| Covid-19 pneumonia | 31 | 2.5% | 6 | 31 |
| Diarrhoea | 28 | 2.3% | 4 | 11 |
Other Indications for TECLISTAMAB
Plasma cell myeloma (736)
Product used for unknown indication (251)
Plasma cell myeloma refractory (205)
Other Drugs Used for Primary amyloidosis
BORTEZOMIB (905)
DEXAMETHASONE (744)
DARATUMUMAB (609)
CYCLOPHOSPHAMIDE (580)
LENALIDOMIDE (233)
MELPHALAN (163)
POMALIDOMIDE (126)
VENETOCLAX (47)
DARATUMUMAB\HYALURONIDASE-FIHJ (44)
IXAZOMIB (40)